Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 111

1.

Clinical and Neurobehavioral Features of Three Novel Kabuki Syndrome Patients with Mosaic KMT2D Mutations and a Review of Literature.

Lepri FR, Cocciadiferro D, Augello B, Alfieri P, Pes V, Vancini A, Caciolo C, Squeo GM, Malerba N, Adipietro I, Novelli A, Sotgiu S, Gherardi R, Digilio MC, Dallapiccola B, Merla G.

Int J Mol Sci. 2017 Dec 28;19(1). pii: E82. doi: 10.3390/ijms19010082.

2.

HLA-G coding region polymorphism is skewed in autistic spectrum disorders.

Guerini FR, Bolognesi E, Chiappedi M, Ripamonti E, Ghezzo A, Zanette M, Sotgiu S, Mensi MM, Carta A, Canevini MP, Zanzottera M, Agliardi C, Costa AS, Balottin U, Clerici M.

Brain Behav Immun. 2018 Jan;67:308-313. doi: 10.1016/j.bbi.2017.09.007. Epub 2017 Sep 18.

PMID:
28923404
3.

HLA-G∗14bp Insertion and the KIR2DS1-HLAC2 Complex Impact on Behavioral Impairment in Children with Autism Spectrum Disorders.

Guerini FR, Bolognesi E, Chiappedi M, Ghezzo A, Manca S, Zanette M, Sotgiu S, Mensi MM, Zanzottera M, Agliardi C, Costa AS, Balottin U, Clerici M.

Neuroscience. 2018 Feb 1;370:163-169. doi: 10.1016/j.neuroscience.2017.06.012. Epub 2017 Jun 13.

PMID:
28627421
4.

Epidemiology of multiple sclerosis in the pediatric population of Sardinia, Italy.

Dell'Avvento S, Sotgiu MA, Manca S, Sotgiu G, Sotgiu S.

Eur J Pediatr. 2016 Jan;175(1):19-29. doi: 10.1007/s00431-015-2588-3. Epub 2015 Jul 10.

PMID:
26156052
5.

Neurotoxicity and synaptic plasticity impairment of N-acetylglucosamine polymers: implications for Alzheimer's disease.

Turano E, Busetto G, Marconi S, Guzzo F, Farinazzo A, Commisso M, Bistaffa E, Angiari S, Musumeci S, Sotgiu S, Bonetti B.

Neurobiol Aging. 2015 May;36(5):1780-91. doi: 10.1016/j.neurobiolaging.2014.12.033. Epub 2015 Jan 6.

PMID:
25735590
6.

Cleaning of paper artworks: development of an efficient gel-based material able to remove starch paste.

Mazzuca C, Micheli L, Cervelli E, Basoli F, Cencetti C, Coviello T, Iannuccelli S, Sotgiu S, Palleschi A.

ACS Appl Mater Interfaces. 2014 Oct 8;6(19):16519-28. doi: 10.1021/am504295n. Epub 2014 Sep 26.

PMID:
25216156
7.

MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patients.

Serana F, Imberti L, Amato MP, Comi G, Gasperini C, Ghezzi A, Martinelli V, Provinciali L, Rottoli MR, Sotgiu S, Stecchi S, Vecchio M, Zaffaroni M, Cordioli C, Capra R.

PLoS One. 2014 Apr 14;9(4):e94794. doi: 10.1371/journal.pone.0094794. eCollection 2014.

8.

Molecular analysis, pathogenic mechanisms, and readthrough therapy on a large cohort of Kabuki syndrome patients.

Micale L, Augello B, Maffeo C, Selicorni A, Zucchetti F, Fusco C, De Nittis P, Pellico MT, Mandriani B, Fischetto R, Boccone L, Silengo M, Biamino E, Perria C, Sotgiu S, Serra G, Lapi E, Neri M, Ferlini A, Cavaliere ML, Chiurazzi P, Monica MD, Scarano G, Faravelli F, Ferrari P, Mazzanti L, Pilotta A, Patricelli MG, Bedeschi MF, Benedicenti F, Prontera P, Toschi B, Salviati L, Melis D, Di Battista E, Vancini A, Garavelli L, Zelante L, Merla G.

Hum Mutat. 2014 Jul;35(7):841-50. doi: 10.1002/humu.22547. Epub 2014 Apr 9.

9.

Gellan hydrogel as a powerful tool in paper cleaning process: a detailed study.

Mazzuca C, Micheli L, Carbone M, Basoli F, Cervelli E, Iannuccelli S, Sotgiu S, Palleschi A.

J Colloid Interface Sci. 2014 Feb 15;416:205-11. doi: 10.1016/j.jcis.2013.10.062. Epub 2013 Nov 8.

PMID:
24370423
10.

Role of SH levels and markers of immune response in the stroke.

Musumeci M, Sotgiu S, Persichilli S, Arru G, Angeletti S, Fois ML, Minucci A, Musumeci S.

Dis Markers. 2013;35(3):141-7. doi: 10.1155/2013/246205. Epub 2013 Aug 20.

11.

Activating KIR molecules and their cognate ligands prevail in children with a diagnosis of ASD and in their mothers.

Guerini FR, Bolognesi E, Chiappedi M, Manca S, Ghezzo A, Agliardi C, Zanette M, Littera R, Carcassi C, Sotgiu S, Clerici M.

Brain Behav Immun. 2014 Feb;36:54-60. doi: 10.1016/j.bbi.2013.10.006. Epub 2013 Oct 11.

PMID:
24120931
12.

Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study.

Arru G, Leoni S, Pugliatti M, Mei A, Serra C, Delogu LG, Manetti R, Dolei A, Sotgiu S, Mameli G.

Mult Scler. 2014 Feb;20(2):174-82. doi: 10.1177/1352458513494957. Epub 2013 Jul 22.

PMID:
23877972
13.

Re: Errors in the editorial by Christensen and Giovannoni [HERVs: have we been here before? MSJ 18(12) 1670-1672].

Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, Farinelli L, Faucard R, Veas F, Stefas I, Fabriek BO, Van-Horssen J, Vander-Valk P, Gerdil C, Mancuso R, Saresella M, Clerici M, Marcel S, Creange A, Cavaretta R, Caputo D, Arru G, Morand P, Lang AB, Sotgiu S, Ruprecht K, Rieckmann P, Villoslada P, Chofflon M, Boucraut J, Pelletier J, Hartung HP.

Mult Scler. 2013 May;19(6):831-2. doi: 10.1177/1352458513485150. No abstract available.

PMID:
23658240
14.

Protein-protein interaction analysis highlights additional loci of interest for multiple sclerosis.

Ragnedda G, Disanto G, Giovannoni G, Ebers GC, Sotgiu S, Ramagopalan SV.

PLoS One. 2012;7(10):e46730. doi: 10.1371/journal.pone.0046730. Epub 2012 Oct 18.

15.

Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis.

Mameli G, Poddighe L, Mei A, Uleri E, Sotgiu S, Serra C, Manetti R, Dolei A.

PLoS One. 2012;7(9):e44991. doi: 10.1371/journal.pone.0044991. Epub 2012 Sep 27.

16.

Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease.

Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, Farinelli L, Faucard R, Veas F, Stefas I, Fabriek BO, Van-Horssen J, Van-der-Valk P, Gerdil C, Mancuso R, Saresella M, Clerici M, Marcel S, Creange A, Cavaretta R, Caputo D, Arru G, Morand P, Lang AB, Sotgiu S, Ruprecht K, Rieckmann P, Villoslada P, Chofflon M, Boucraut J, Pelletier J, Hartung HP.

Mult Scler. 2012 Dec;18(12):1721-36. doi: 10.1177/1352458512441381. Epub 2012 Mar 28.

17.

Cytoskeletal proteins in the cerebrospinal fluid as biomarker of multiple sclerosis.

Madeddu R, Farace C, Tolu P, Solinas G, Asara Y, Sotgiu MA, Delogu LG, Prados JC, Sotgiu S, Montella A.

Neurol Sci. 2013 Feb;34(2):181-6. doi: 10.1007/s10072-012-0974-4. Epub 2012 Feb 24.

PMID:
22362332
18.

The Indian drawings of the poet Cesare Pascarella: non-destructive analyses and conservation treatments.

Bicchieri M, Monti M, Piantanida G, Pinzari F, Iannuccelli S, Sotgiu S, Tireni L.

Anal Bioanal Chem. 2012 Feb;402(4):1517-28. doi: 10.1007/s00216-011-5229-3. Epub 2011 Jul 13.

PMID:
21750878
19.

SNAP-25 single nucleotide polymorphisms are associated with hyperactivity in autism spectrum disorders.

Guerini FR, Bolognesi E, Chiappedi M, Manca S, Ghezzo A, Agliardi C, Sotgiu S, Usai S, Matteoli M, Clerici M.

Pharmacol Res. 2011 Sep;64(3):283-8. doi: 10.1016/j.phrs.2011.03.015. Epub 2011 Apr 8.

PMID:
21497654
20.

Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group--Italian Neurological Society.

Ghezzi A, Grimaldi LM, Marrosu MG, Pozzilli C, Comi G, Bertolotto A, Trojano M, Gallo P, Capra R, Centonze D, Millefiorini E, Sotgiu S, Brescia Morra V, Amato MP, Lugaresi A, Mancardi G, Caputo D, Montanari E, Provinciali L, Durelli L, Bergamaschi R, Bellantonio P, Tola MR, Cottone S, Savettieri G, Tedeschi G; MS-SIN Study Group.

Neurol Sci. 2011 Apr;32(2):351-8. doi: 10.1007/s10072-010-0469-0.

PMID:
21234775

Supplemental Content

Loading ...
Support Center